Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many
organisms and are promising candidates to treat infections caused by pathogenic bacteria to …

Drug resistance is one of the biggest challenges in cancer treatment and limits the potential
to cure patients. In many tumors, sustained activation of the protein NRF2 makes tumor cells …

Cancer stem cells (CSCs) have been reported to play critical roles in tumor initiation,
propagation, and regeneration of cancer. Nano-size vehicles are employed to deliver drugs …

Anticancer peptides (ACPs) are a kind of bioactive peptides which could be used as a novel
type of anticancer drug that has several advantages over chemistry-based drug, including …

Multidrug resistance (MDR) is a major obstacle to successful cancer treatment and is crucial
to cancer metastasis and relapse. Combination therapy is an effective strategy for …

Simple Summary With 19.3 million new cancer cases worldwide and nearly 10.0 million
cancer-related deaths cancer is a global health challenge. Cancer is a disease caused by a …

In recent times, scientific attention has been paid to different foods and their bioactive
components for the ability to inhibit the onset and progress of different types of cancer …

DNA methylation is one of the main epigenetic mechanisms in cancer development and
progression. Aberrant DNA methylation of CpG islands within promoter regions contributes …

Nowadays, cancer therapy remains limited by the conventional one-size-fits-all approach. In
this context, treatment decisions are based on the clinical stage of disease but fail to …

The HOXA9 transcription factor serves as a molecular orchestrator in cancer stemness,
epithelial-mesenchymal transition (EMT), metastasis, and generation of the tumor …